- 1 in 3 lupus cases are initially misdiagnosed due to symptom overlap with more common illnesses like Lyme disease.
- Lupus cannot be confirmed with a single test and requires a combination of clinical evaluation, blood work, and symptom tracking.
- Doctors in areas with high Lyme prevalence may prioritize testing for Lyme over rarer conditions like lupus.
- Early intervention is critical for managing lupus, making accurate diagnosis essential.
- Autoimmune disorders like lupus often present with flu-like or infectious disease symptoms, complicating diagnosis.
How many people are suffering from undiagnosed lupus because their symptoms mimic more common illnesses like Lyme disease? For Brie Hyde, a dairy farmer from upstate New York, the answer came after nearly a decade of confusion, worsening health, and ineffective treatments. Like thousands of others, Hyde’s joint pain, chronic fatigue, and brain fog were initially attributed to Lyme disease — a tick-borne infection prevalent in her region. But repeated treatments failed to improve her condition. Her case raises urgent questions about diagnostic accuracy, especially when autoimmune disorders present with flu-like or infectious disease symptoms. If one of the most treatable windows for managing lupus is early intervention, how are so many patients slipping through the cracks?
Why Was Brie Hyde Misdiagnosed for So Long?
Hyde’s misdiagnosis stemmed from symptom overlap between Lyme disease and systemic lupus erythematosus (SLE), an autoimmune condition where the body attacks its own tissues. Both illnesses can cause fatigue, joint swelling, fever, and cognitive difficulties. In areas like the Northeastern United States, where Lyme is endemic, doctors often prioritize testing for the infection over rarer conditions. Hyde’s active outdoor lifestyle and exposure to livestock made Lyme a plausible first assumption. However, unlike Lyme, lupus cannot be confirmed with a single test — it requires a combination of clinical evaluation, blood work, and symptom tracking over time. According to the Centers for Disease Control and Prevention (CDC), this complexity leads to an average diagnosis delay of six years. For Hyde, that meant years of antibiotics, missed work, and declining health before a rheumatologist identified elevated antinuclear antibodies (ANA) and other markers confirming lupus.
What Evidence Supports the Lupus Diagnosis?
The turning point came when Hyde sought a second opinion at a specialty clinic in Rochester, NY. There, physicians conducted a full autoimmune panel, including anti-dsDNA and complement protein tests — key indicators of lupus activity. Her ANA test returned strongly positive, and she exhibited several of the American College of Rheumatology’s 11 criteria for lupus, including photosensitivity, oral ulcers, and serositis. Dr. Elena Martinez, the rheumatologist who led her care, noted that Hyde’s lack of response to antibiotics and absence of the classic Lyme rash (erythema migrans) should have prompted earlier reconsideration. A 2023 review in Nature Reviews Rheumatology found that up to 30% of patients referred to lupus clinics had previously been misdiagnosed with Lyme or chronic fatigue syndrome. The study emphasized the need for better provider education on autoimmune mimicry and access to rheumatology specialists, particularly in rural areas.
Are There Valid Reasons to Suspect Lyme Over Lupus?
Some clinicians argue that in high-Lyme-prevalence regions, starting with that diagnosis is a reasonable precaution. Dr. Alan Stern, an infectious disease specialist at Upstate Medical University, explains: “When a patient presents with fatigue, arthralgia, and lives in a wooded area, Lyme is a logical first consideration — especially if they recall a tick bite.” He adds that early antibiotic treatment can prevent serious complications if Lyme is indeed present. However, he acknowledges that over-reliance on this pathway risks delaying care for patients with autoimmune conditions. Skeptics also point out that “chronic Lyme” — a controversial and medically unverified diagnosis — has led some practitioners to extend antibiotic use indefinitely without confirming infection, potentially masking other diseases. The World Health Organization (WHO) warns that such practices complicate differential diagnosis and may harm patients through unnecessary treatments.
What Are the Real-World Consequences of Misdiagnosis?
For Hyde, the consequences were profound. She lost the ability to work full-time on her family’s farm, missed her sister’s wedding due to a flare-up, and struggled with depression as her health declined. Misdiagnosis also carried financial strain — repeated tests, specialist visits, and ineffective treatments accumulated tens of thousands in medical bills. Nationally, delayed lupus diagnosis correlates with higher rates of organ damage, particularly to the kidneys and cardiovascular system. A 2022 study in Arthritis & Rheumatology showed that patients diagnosed more than five years after symptom onset were twice as likely to develop lupus nephritis. Hyde now manages her condition with hydroxychloroquine and regular monitoring, but she emphasizes that earlier intervention could have prevented irreversible joint damage and prolonged disability.
What This Means For You
If you or a loved one experiences persistent, unexplained fatigue, joint pain, or skin rashes, especially if treatments aren’t working, consider seeking a rheumatology consultation. Lupus affects an estimated 1.5 million Americans, predominantly women of childbearing age, and early diagnosis improves long-term outcomes. Keep a symptom diary and request comprehensive autoimmune testing if suspicions arise. Awareness and advocacy can make the difference between years of uncertainty and timely, effective care.
As diagnostic protocols evolve, a critical question remains: How can healthcare systems better distinguish between infectious and autoimmune conditions in their earliest stages? With rising rates of both Lyme disease and autoimmune disorders, the answer may lie in integrated diagnostic pathways, expanded specialist access, and greater emphasis on patient-reported outcomes.
Source: Healthline